Literature DB >> 1425105

Identifying diabetic patients at high risk for lower-extremity amputation in a primary health care setting. A prospective evaluation of simple screening criteria.

S J Rith-Najarian1, T Stolusky, D M Gohdes.   

Abstract

OBJECTIVE: To evaluate prospectively a risk categorization scheme for lower-extremity problems that incorporates the Semmes-Weinstein 5.07 monofilament and a simple exam to stratify patients who were followed in a primary-care setting into risk groups for plantar ulceration and lower-extremity amputation. RESEARCH DESIGN AND METHODS: Patients with diabetes in a well-defined American-Indian population were stratified into four risk categories based on sensation status to the 5.07 monofilament, the presence of foot deformity, and a history of lower-extremity events (amputation or ulceration): category 0, sensate; category 1, insensate; category 2, insensate with deformity; and category 3, history of lower extremity events. Patients were followed prospectively for lower extremity events and changes in sensation status.
RESULTS: We gave screening exams to 358 (88%) of 406 individuals with diabetes in the community. The distribution of patients for risk categories 0, 1, 2, and 3 was 74.3, 8.4, 4.5, and 13%, respectively. Over a 32-mo follow-up period, 41 patients developed ulcerations, and incidence rates correlated positively with increasing risk category (P less than 0.00001). All 14 amputations occurred in risk groups 2 and 3.
CONCLUSIONS: These data suggest that the risk categorization described here may have a role in identifying patients at risk for lower extremity events who are followed in a primary-care setting.

Entities:  

Mesh:

Year:  1992        PMID: 1425105     DOI: 10.2337/diacare.15.10.1386

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  43 in total

Review 1.  Cost-effective management of diabetic foot ulcers. A review.

Authors:  G Ragnarson-Tennvall; J Apelqvist
Journal:  Pharmacoeconomics       Date:  1997-07       Impact factor: 4.981

Review 2.  Risk factors for diabetic neuropathy and foot ulceration.

Authors:  A Adler
Journal:  Curr Diab Rep       Date:  2001-12       Impact factor: 4.810

3.  Preulcerous Risk Situation in Diabetic Foot Syndrome: Proposal for a Simple Ulcer Prevention Score.

Authors:  Stephan Kress; Helmut Anderten; Anja Borck; Guido Freckmann; Lutz Heinemann; Ulrike Holzmüller; Bernd Kulzer; Alexandra Portele; Oliver Schnell; Helga Varlemann; Claudia Zemmrich; Ralf Lobmann
Journal:  J Diabetes Sci Technol       Date:  2020-06-10

4.  Subclinical diabetic neuropathy with normal conventional electrophysiological study.

Authors:  Jong Seok Bae; Byoung Joon Kim
Journal:  J Neurol       Date:  2007-02-14       Impact factor: 4.849

Review 5.  Screening, prevention, counseling, and treatment for the complications of type II diabetes mellitus. Putting evidence into practice.

Authors:  S Vijan; D L Stevens; W H Herman; M M Funnell; C J Standiford
Journal:  J Gen Intern Med       Date:  1997-09       Impact factor: 5.128

6.  Diagnostic performance of two-dimensional shear wave elastography for evaluating tibial nerve stiffness in patients with diabetic peripheral neuropathy.

Authors:  Weixi Jiang; Sirun Huang; Hua Teng; Peipei Wang; Meng Wu; Xia Zhou; Weiwei Xu; Qunxia Zhang; Haitao Ran
Journal:  Eur Radiol       Date:  2018-11-28       Impact factor: 5.315

Review 7.  The epidemiology of neuropathic foot ulcers in individuals with diabetes.

Authors:  Jay Sosenko
Journal:  Curr Diab Rep       Date:  2002-12       Impact factor: 4.810

Review 8.  Diagnosis and management of diabetic neuropathy.

Authors:  Bruce A Perkins; Vera Bril
Journal:  Curr Diab Rep       Date:  2002-12       Impact factor: 4.810

Review 9.  Diabetes: foot ulcers and amputations.

Authors:  Dereck Hunt
Journal:  BMJ Clin Evid       Date:  2009-01-12

10.  Prediction of incident diabetic neuropathy using the monofilament examination: a 4-year prospective study.

Authors:  Bruce A Perkins; Andrej Orszag; Mylan Ngo; Eduardo Ng; Patti New; Vera Bril
Journal:  Diabetes Care       Date:  2010-03-31       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.